A four-year prospective study of cognitive functioning in Huntington's disease

Journal of the International Neuropsychological Society

Volumn 12, Issue 4, 2006, Pages 445-454

  Ward, Julianna ^a   Sheppard, Jeannie Marie ^a   Shpritz, Barnett ^a   Margolis, Russell L ^a   Rosenblatt, Adam ^a   Brant, Jason ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Basal ganglia; Huntington's disease; Longitudinal; Neurologic dysfunction; Prospective; Trinucleotide repeats

Indexed keywords

ADULT; ARTICLE; BASAL GANGLION; BRAIN DEGENERATION; BRAIN FUNCTION; COGNITION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; FEMALE; FOLLOW UP; GENETIC PARAMETERS; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; MOTOR PERFORMANCE; NERVOUS SYSTEM PARAMETERS; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEOTIDE REPEAT; PERFORMANCE; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOMOTOR PERFORMANCE; STATISTICAL MODEL; VISION;

ADULT; BASAL GANGLIA; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TRAIL MAKING TEST; TRINUCLEOTIDE REPEATS;

EID: 33746087567     PISSN: 13556177     EISSN: 14697661     Source Type: Journal    
DOI: 10.1017/S1355617706060747     Document Type: Article

References (28)

1. Bamford, K.A., Caine, E.D., Kido, D.K., Cox, C., & Shoulson, I. (1995). A prospective evaluation of cognitive decline in early Huntington's disease: Functional and radiographic correlates. Neurology, 45, 1867-1873.
2. Bauchoud-Levi, A.C., Maison, P., Bartolomeo, P., Boisse, M.F., Barba, G.D., Ergis, A.M., Baudic, S., Degos, J.D., Cesaro, P., & Peschanski, M. (2001). Retest effects and cognitive decline in longitudinal follow-up of patients with early HD. Neurology, 56, 1052-1058.
3. Brandt, J. (1991). Cognitive impairments in Huntington's disease: Insights into the neuropsychology of the striatum. In F. Boller & J. Grafman (eds.), Handbook of neuropsychology (pp. 241-264). Amsterdam: Elsevier.
4. Brandt, J., Bylsma, F.W., Gross, R., Stine, O.C., Ranen, N., & Ross, C.A. (1996). Trinucleotide repeat length and clinical progression in Huntington's disease. Neurology, 46, 527-531.
5. Brandt, J., Strauss, M.E., Larus, J., Jensen, B., Folstein, S.E., & Folstein, M.F. (1984). Clinical correlates of dementia and disability in Huntington's disease. Journal of Clinical Neuropsychology, 6, 401-412.
6. Brinkman, R.R., Mezei, M.M., Theilmann, J., Almqvist, E., & Hayden, M.R. (1997). The likelihood of being affected with Huntington's disease by a particular age, for a specific CAG size. American Journal of Human Genetics, 60, 1202-1210.
7. Butters, N., Sax, D., Montgomery, K., & Tarlow, S. (1978). Comparison of the neuropsychological deficits associated with early and advanced Huntington's disease. Archives of Neurology, 35, 585-589.
8. Bylsma, F.W., Rothlind, J., Hall, M.R., Folstein, S.E., & Brandt, J. (1993). Assessment of adaptive function in Huntington's disease. Movement Disorders, 8, 183-190.
9. Folstein, S.E. (1989). Huntington's disease: A disorder of families. Baltimore, MD: Johns Hopkins University Press.
10. Folstein, S.E., Jensen, B., Leigh, R.J., & Folstein, M.F. (1983). The measurement of abnormal movement: Methods developed for Huntington's disease. Neurobehavioral Toxicology and Teratology, 5, 605-609.
11. Foroud, T., Siemers, E., Kleindorfer, D., Bill, D.J., Hodes, M.E., Norton, J.A., Conneally, P.M., & Christian, J.C. (1995). Cognitive scores in carriers of Huntington's disease gene compared to noncarriers. Annals of Neurology, 37, 657-664.
12. Gomez-Tortosa, E., Barrio, A.D., Ruiz, P.J.G., Pernaute, R.S., Benitez, J., Barroso, A., Jimenez, J., & Yebenes, J.G. (1998). Severity of cognitive impairment in juvenile and late-onset Huntington's disease. Archives of Neurology, 55, 835-843.
13. Huntington's Disease Collaborative Research Group (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell, 72, 971-983.
14. Hahn-Barma, V., Deweer, B., Durr, A., Dode, C., Feingold, J., Pillon, B., Agid, Y., Brice, A., & Dubois, B. (1998). Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers. Journal of Neurology, Neurosurgery, and Psychiatry, 64, 172-177.
15. Ho, A.K., Sahakian, B.J., Brown, R.G., Barker, R.A., Hodges, J.R., Ane, M.N., Snowden, J., Thompson, J., Esmonde, T., Gentry, R., Moore, J.W., & Bodner, T. (2003). Profile of cognitive progression in early Huntington's disease. Neurology, 61, 1702-1706.
16. Joel, D. (2001). Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease. Movement Disorders, 16, 407-423.
17. Kirkwood, S.C., Su, J.L., Conneally, P.M., & Foroud, T. (2001). Progression of symptoms in early and middle stages of Huntington disease. Archives of Neurology, 58, 273-278.
18. Lawrence, A.D., Sahakian, B.J., Hodges, J.R., Rosser, A.E., Lange, K.W., & Robbins, T.W. (1996). Executive and mnemonic functions in early Huntington's disease. Brain, 119, 1633-1645.
19. Mahant, N., McCusker, E.A., Byth, K., & Graham, S. (2003). Huntington's disease: Clinical correlates of disability and progression. Neurology, 61, 1085-1092.
20. Middleton, F.A. & Strick, P.L. (2002). Basal-ganglia projections to the prefrontal cortex of the primate. Cerebral Cortex, 12, 926-935.
21. Mohr, E., Brouwers, P., Claus, J.J., Mann, U.M., Fedio, P., & Chase, T.N. (1991). Visuospatial cognition in Huntington's disease. Movement Disorders, 6, 127-132.
22. Nehl, C. & Paulsen, J.S. (2004). Cognitive and psychiatric aspects of Huntington's disease coontribute to functional capacity. Journal of Nervous and Mental Disease, 192, 72-74.
23. Rosenblatt, A., Liang, K.Y., Zhou, H., Abbott, M.H., Gourley, L.M., Margolis, R.L., Brandt, J., & Ross, C.A. (2006). The association of CAG repeat length with clinical progression in Huntington's disease. Neurology, 66, 1016-1020.
24. Rothlind, J.C., Bylsma, F.W., Peyser, C., Folstein, S.E., & Brandt, J. (1993). Cognitive and motor corelates of everyday functioning in early Huntington's disease. Journal of Nervous and Mental Disease, 181, 194-199.
25. Snowden, J., Craufurd, D., Griffiths, H., Thompson, J., & Neary, D. (2001). Longitudinal evaluation of cognitive disorder in Huntington's disease. Journal of the International Neuropsychological Society, 7, 33-44.
26. Stine, O.C., Pleasant, N., Franz, M.L., Abbott, M.H., Folstein, S.E., & Ross, C.A. (1993). Correlation between onset age of Huntington's disease and the length of the trinucleotide repeat in IT-15. Human Molecular Genetics, 2, 1247-1249.
27. Wechsler, D. (1981). Wechsler Adult Intelligence Scale-Revised (WAIS-R) Manual. New York, NY: The Psychological Corporation.
28. Witjes-Ane, M.N.W., van der Vlis, M.V., van Vugt, J.P.P., Lanser, J.B.K., Hermans, J., Zwindermann, A.H., Ommen, G.J.B. v., & Roos, R.A.C. (2003). Cognitive and motor functioning in gene carriers for Huntington's disease: A baseline study. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 7-16.